00867 China Medical System Holdings Ltd.

NOTICE TO DISREGARD -- China Medical System Holdings Ltd.

NOTICE TO DISREGARD -- China Medical System Holdings Ltd.

SHENZHEN, CHINA, Dec. 21, 2022 (GLOBE NEWSWIRE) -- We are advised by China Medical System Holdings Ltd. that journalists and other readers should disregard the news release, "CMS (867.HK) Joins Hand with Incyte on Ruxolitinib Cream, Brings 1st Repigmentation Drug for Vitiligo Patient" issued December 6, 2022, over GlobeNewswire.



EN
21/12/2022

Underlying

00867China Medical System Holdings Ltd.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on China Medical System Holdings Ltd.

 PRESS RELEASE
Free
00867 China Medical S...

China Medical System （867.HK, 8A8.SG）NDA for the Improved New Drug ZUN...

China Medical System （867.HK, 8A8.SG）NDA for the Improved New Drug ZUNVEYL for Alzheimer’s Disease Accepted in China SHENZHEN, CHINA, July 28, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) (“ZUNVEYL” or the “Product”) has been accepted by the National Medical Products Administration of China (NMPA). The Product is indicated for the treatment of mild-to-moderate dementia of the Alzheimer’s type i...

July 28, 2025 1 EN
 PRESS RELEASE
Free
00867 China Medical S...

A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore ...

A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today SHENZHEN, CHINA, July 15, 2025 (GLOBE NEWSWIRE) -- On the morning of 15 July 2025, China Medical System Holdings Limited (“CMS” or the “Group”) rang the ceremonial bell to mark its official listing on the Singapore Exchange Main Board (Stock Abbreviation: CMS, Stock Code: 8A8). Nearly one hundred representatives from global professional institutions, shareholders, business partners and employees gathered to witness this strategic moment. Following its successful IPO on the Hong Kong Stock Ex...

July 15, 2025 1 EN
 PRESS RELEASE
Free
00867 China Medical S...

China Medical System Holdings Limited: Proposed Secondary Listing on t...

China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange SHENZHEN, CHINA, June 25, 2025 (GLOBE NEWSWIRE) -- The board of directors of China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group”) announces the proposed secondary listing of the Company’s ordinary shares (“Shares”) on the Singapore Exchange Securities Trading Limited (the “SGX-ST”) by way of introduction (the “Proposed Secondary Listing”). The Proposed Secondary Listing, if proceeded, will not involve issuance of new shares, and the Shares will continue...

June 25, 2025 1 EN
Free Trial
00867 China Medical S...

China Medical System Holdings Ltd: 1 director

A director at China Medical System Holdings Ltd sold 3,000,000 shares at 11.536HKD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...

00867 CHINA MEDICAL SYSTEM HOLDINGS LTD.
06/18/25 June 18, 2025 1 EN
 PRESS RELEASE
Free
00867 China Medical S...

China Medical System （00867） Released its 2024 Annual Results: Focusin...

China Medical System （00867） Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum SHENZHEN, CHINA, March 21, 2025 (GLOBE NEWSWIRE) -- On March 17, China Medical System Holdings Limited (“CMS” or the “Company”) released its 2024 annual results. The Company recorded a turnover of RMB7,469 million, representing a year-on-year decrease of 6.8%; in the case that all medicines were directly sold by the Company, the turnover would be RMB8,622 million, representing a year-on-year decrease of 9.0%. Profit for the year was RMB1,613 million,...

March 21, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch